GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Innate Pharma SA (XPAR:IPH) » Definitions » Other Current Payables

Innate Pharma (XPAR:IPH) Other Current Payables : €1.11 Mil (As of Jun. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Innate Pharma Other Current Payables?

Innate Pharma's Other Current Payables for the quarter that ended in Jun. 2024 was €1.11 Mil.

Innate Pharma's quarterly Other Current Payables increased from Jun. 2023 (€0.00 Mil) to Dec. 2023 (€1.44 Mil) but then declined from Dec. 2023 (€1.44 Mil) to Jun. 2024 (€1.11 Mil).

Innate Pharma's annual Other Current Payables declined from Dec. 2021 (€6.38 Mil) to Dec. 2022 (€1.28 Mil) but then increased from Dec. 2022 (€1.28 Mil) to Dec. 2023 (€1.44 Mil).


Innate Pharma Other Current Payables Historical Data

The historical data trend for Innate Pharma's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innate Pharma Other Current Payables Chart

Innate Pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.57 0.48 6.38 1.28 1.44

Innate Pharma Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 1.28 - 1.44 1.11

Innate Pharma Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Innate Pharma Other Current Payables Related Terms

Thank you for viewing the detailed overview of Innate Pharma's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Innate Pharma Business Description

Address
117, Avenue de Luminy, Marseille, FRA, 13009
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

Innate Pharma Headlines

No Headlines